KVUE · Kenvue Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted earnings per share (non-GAAP) non-GAAP | $0.63 | Fiscal Six Months Ended June 28, 2026 | — |
|
|
|||
| Adjusted Effective tax rate (non-GAAP) non-GAAP | 25.2% | Fiscal Six Months Ended June 28, 2026 | — |
|
|
|||
| EBITDA (non-GAAP) non-GAAP | $831M | Fiscal Three Months Ended June 28, 2026 | — |
|
|
|||
| EBITDA margin (non-GAAP) non-GAAP | 22.1% | Fiscal Six Months Ended June 28, 2026 | — |
|
|
|||
| Free cash flow (non-GAAP) non-GAAP | $1B | Fiscal Six Months Ended June 28, 2026 | — |
| Adjusted gross profit margin non-GAAP | 60.8% | First quarter 2026 | — |
|
|
|||
| Organic sales non-GAAP | 0.7% | First quarter 2026 | — |
| Adjusted operating income margin non-GAAP | 19.9% | Fiscal Three Months Ended December 28, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KVUE
this stock
Kenvue Inc.
|
$36.09B | +10.9% | -2.1% | — | 3.3% |
|
PG
PROCTER & GAMBLE Co
|
$334.03B | +0.7% | +3.3% | 21.7 | 1.2% |
|
UL
Unilever PLC
|
$133.57B | -3.4% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$72.90B | +15.0% | +1.7% | 36.2 | 2.2% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$43.39B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KVUE | +0.8% | +0.0% | +0.7% | -0.6% | +10.9% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +1.2% | -2.9% | -10.9% | -3.5% | -1.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.